107 related articles for article (PubMed ID: 6345995)
21. Early deficits in insulin secretion, beta cell mass and islet blood perfusion precede onset of autoimmune type 1 diabetes in BioBreeding rats.
Medina A; Parween S; Ullsten S; Vishnu N; Siu YT; Quach M; Bennet H; Balhuizen A; Åkesson L; Wierup N; Carlsson PO; Ahlgren U; Lernmark Å; Fex M
Diabetologia; 2018 Apr; 61(4):896-905. PubMed ID: 29209740
[TBL] [Abstract][Full Text] [Related]
22. Impaired insulin secretion in the spontaneous diabetes rats.
Kimura K; Toyota T; Kakizaki M; Kudo M; Takebe K; Goto Y
Tohoku J Exp Med; 1982 Aug; 137(4):453-9. PubMed ID: 6750845
[TBL] [Abstract][Full Text] [Related]
23. Unresponsiveness to glucose in a streptozocin model of diabetes. Inappropriate insulin and glucagon responses to a reduction of glucose concentration.
Leahy JL; Weir GC
Diabetes; 1985 Jul; 34(7):653-9. PubMed ID: 2861128
[TBL] [Abstract][Full Text] [Related]
24. Insulin, glucagon, and somatostatin secretion from isolated perfused rat and chicken pancreas-duodenum.
Honey RN; Schwarz JA; Mathe CJ; Weir GC
Am J Physiol; 1980 Feb; 238(2):E150-6. PubMed ID: 6444782
[TBL] [Abstract][Full Text] [Related]
25. Elevated proinsulin biosynthesis in vitro from a rat model of non-insulin-dependent diabetes mellitus.
Halban PA; Bonner-Weir S; Weir GC
Diabetes; 1983 Mar; 32(3):277-83. PubMed ID: 6337906
[TBL] [Abstract][Full Text] [Related]
26. Differential beta-cell response to glucose, glucagon, and arginine during progression to type I (insulin-dependent) diabetes mellitus.
Chaillous L; Rohmer V; Maugendre D; Lecomte P; Maréchaud R; Marre M; Guilhem I; Charbonnel B; Saï P
Metabolism; 1996 Mar; 45(3):306-14. PubMed ID: 8606636
[TBL] [Abstract][Full Text] [Related]
27. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
[TBL] [Abstract][Full Text] [Related]
28. Glucose control and long-term survival in biobreeding/Worcester rats after intraperitoneal implantation of hydrophilic macrobeads containing porcine islets without immunosuppression.
Jain K; Asina S; Yang H; Blount ED; Smith BH; Diehl CH; Rubin AL
Transplantation; 1999 Dec; 68(11):1693-700. PubMed ID: 10609945
[TBL] [Abstract][Full Text] [Related]
29. Differential sensitivity to beta-cell secretagogues in "early," type I diabetes mellitus.
Ganda OP; Srikanta S; Brink SJ; Morris MA; Gleason RE; Soeldner JS; Eisenbarth GS
Diabetes; 1984 Jun; 33(6):516-21. PubMed ID: 6373458
[TBL] [Abstract][Full Text] [Related]
30. Pancreatic function of spontaneously diabetic torii rats in pre-diabetic stage.
Matsui K; Oda T; Nishizawa E; Sano R; Yamamoto H; Fukuda S; Sasase T; Miyajima K; Ueda N; Ishii Y; Ohta T; Matsushita M
Exp Anim; 2009 Jul; 58(4):363-74. PubMed ID: 19654434
[TBL] [Abstract][Full Text] [Related]
31. Somatostatin, glucagon, and insulin secretion from perfused pancreas of BB rats.
Ruggere MD; Patel YC
Am J Physiol; 1984 Aug; 247(2 Pt 1):E221-7. PubMed ID: 6147095
[TBL] [Abstract][Full Text] [Related]
32. Glucose tolerance and insulin secretion in children of mothers with pregestational IDDM or gestational diabetes.
Plagemann A; Harder T; Kohlhoff R; Rohde W; Dörner G
Diabetologia; 1997 Sep; 40(9):1094-100. PubMed ID: 9300247
[TBL] [Abstract][Full Text] [Related]
33. Abnormal insulin secretion in a streptozocin model of diabetes. Effects of insulin treatment.
Leahy JL; Bonner-Weir S; Weir GC
Diabetes; 1985 Jul; 34(7):660-6. PubMed ID: 2408948
[TBL] [Abstract][Full Text] [Related]
34. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose.
Greenbaum CJ; Prigeon RL; D'Alessio DA
Diabetes; 2002 Apr; 51(4):951-7. PubMed ID: 11916912
[TBL] [Abstract][Full Text] [Related]
35. Insulin secretion and islet endocrine cell content at onset and during the early stages of diabetes in the BB rat: effect of the level of glycemic control.
Pederson RA; Curtis SB; Chisholm CB; Gaba NR; Campos RV; Brown JC
Can J Physiol Pharmacol; 1991 Aug; 69(8):1230-6. PubMed ID: 1782606
[TBL] [Abstract][Full Text] [Related]
36. Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GK rat.
Movassat J; Saulnier C; Serradas P; Portha B
Diabetologia; 1997 Aug; 40(8):916-25. PubMed ID: 9267986
[TBL] [Abstract][Full Text] [Related]
37. Modulation of A and B cell functions by tolbutamide and arginine in the pancreas of thiamine-deficient rats.
Rathanaswami P; Sundaresan R
Biochem Int; 1989 Oct; 19(4):793-802. PubMed ID: 2695088
[TBL] [Abstract][Full Text] [Related]
38. Absence of glucopenic inhibition of the insulin response to arginine at the onset of diabetes in BB/W rats.
Komiya I; Unger RH
Diabetologia; 1988 Apr; 31(4):225-7. PubMed ID: 3290019
[TBL] [Abstract][Full Text] [Related]
39. Pathophysiology of insulin secretion in diabetes mellitus.
Ward WK; Beard JC; Halter JB; Porte D
Adv Exp Med Biol; 1985; 189():137-58. PubMed ID: 3898762
[TBL] [Abstract][Full Text] [Related]
40. Bioactive GLP-1 in gut, receptor expression in pancreas, and insulin response to GLP-1 in diabetes-prone rats.
Valverde I; Wang GS; Burghardt K; Kauri LM; Redondo A; Acitores A; Villanueva-Peñacarrillo ML; Courtois P; Sener A; Cancelas J; Malaisse WJ; Scott FW
Endocrine; 2004 Feb; 23(1):77-84. PubMed ID: 15034199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
